Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 15782081)

1.

An open-label trial of escitalopram in pervasive developmental disorders.

Owley T, Walton L, Salt J, Guter SJ Jr, Winnega M, Leventhal BL, Cook EH Jr.

J Am Acad Child Adolesc Psychiatry. 2005 Apr;44(4):343-8.

PMID:
15782081
2.

Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation.

Brodkin ES, McDougle CJ, Naylor ST, Cohen DJ, Price LH.

J Child Adolesc Psychopharmacol. 1997 Summer;7(2):109-21.

PMID:
9334896
3.

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):599-610.

PMID:
17069548
4.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
5.

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):267-77.

PMID:
11642476
6.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
7.

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, Leventhal BL, Cook EH Jr.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):517-24.

PMID:
17069541
8.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
9.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
10.

Open-label study of olanzapine in children with pervasive developmental disorder.

Kemner C, Willemsen-Swinkels SH, de Jonge M, Tuynman-Qua H, van Engeland H.

J Clin Psychopharmacol. 2002 Oct;22(5):455-60.

PMID:
12352267
11.

Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.

Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E.

J Clin Psychiatry. 2008 Mar;69(3):452-6.

PMID:
18312057
12.

Use of citalopram in pervasive developmental disorders.

Namerow L, Thomas P, Bostic JQ, Prince J, Monuteaux MC.

J Dev Behav Pediatr. 2003 Apr;24(2):104-8.

PMID:
12692455
13.

Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.

Wake R, Miyaoka T, Inagaki T, Furuya M, Ieda M, Liaury K, Kishi K, Horiguchi J.

J Child Adolesc Psychopharmacol. 2013 Jun;23(5):329-36. doi: 10.1089/cap.2012.0108.

PMID:
23782127
14.

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.

Gencer O, Emiroglu FN, Miral S, Baykara B, Baykara A, Dirik E.

Eur Child Adolesc Psychiatry. 2008 Jun;17(4):217-25.

PMID:
18026891
15.

A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

Masi G, Cosenza A, Mucci M, Brovedani P.

J Clin Psychiatry. 2003 Sep;64(9):1039-47.

PMID:
14628979
16.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
17.

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.

Davidson JR, Bose A, Korotzer A, Zheng H.

Depress Anxiety. 2004;19(4):234-40.

PMID:
15274172
19.

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Mohamed S, Osatuke K, Aslam M, Kasckow J.

Am J Geriatr Pharmacother. 2006 Sep;4(3):201-9.

PMID:
17062320
20.

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.

Arch Gen Psychiatry. 1998 Jul;55(7):633-41.

PMID:
9672054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk